CHA Biotech Co. Ltd (085660) — Cash Flow Quality Index
CHA Biotech Co. Ltd (085660) has a Cash Flow Quality Index of -0.88x as of September 2024. Operating cash flow of ₩-12.81 Billion is below net income of ₩14.59 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 085660 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CHA Biotech Co. Ltd Cash Flow Quality Index (2009–2019)
Historical Cash Flow Quality Index for CHA Biotech Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of CHA Biotech Co. Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CHA Biotech Co. Ltd (2009–2019)
Year-by-year earnings quality comparison for CHA Biotech Co. Ltd. For live market cap and the full company financial profile, see 085660 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.54x | ₩25.24 Billion | ₩46.37 Billion | ▼ -82.4% |
| 2018 | 3.09x | ₩75.38 Billion | ₩24.39 Billion | ▲ +649.9% |
| 2016 | 0.41x | ₩11.29 Billion | ₩27.40 Billion | ▲ +145.8% |
| 2014 | -0.90x | ₩-2.57 Billion | ₩2.85 Billion | ▼ -134.5% |
| 2013 | 2.61x | ₩66.35 Billion | ₩25.45 Billion | ▲ +39.3% |
| 2012 | 1.87x | ₩45.77 Billion | ₩24.45 Billion | ▼ -78.3% |
| 2011 | 8.64x | ₩34.69 Billion | ₩4.02 Billion | ▲ +4.9% |
| 2010 | 8.24x | ₩42.07 Billion | ₩5.11 Billion | ▲ +86.6% |
| 2009 | 4.41x | ₩24.02 Billion | ₩5.44 Billion | — |